Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Protein Engineering, Design & Selection : PEDS|June 26, 2010
VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabodyTomoyuki Igawa, Hiroyuki Tsunoda, Yasufumi Kikuchi, et al.The AAPS Journal|January 8, 2021
A Novel Total Drug Assay for Quantification of Anti-C5 Therapeutic Monoclonal Antibody in the Presence of Abundant TargetHiroo Watanabe, Mitsuko Shibuya, Norihito Shibahara, et al.Plos One|June 4, 2016
Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking AntibodiesKei Suzuki, Hiroyuki Tsunoda, Ryusuke Omiya, et al.Thrombosis and Haemostasis|April 29, 2017
Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigensTakehisa Kitazawa, Keiko Esaki, Tatsuhiko Tachibana, et al.Journal of Pathology Informatics|October 21, 2022
Digital workflows for pathological assessment of rat estrous cycle stage using images of uterine horn and vaginal tissueShinichi Onishi, Riku Egami, Yuya Nakamura, et al.Cancer Research|December 3, 2008
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancerTakahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanomaYumiko Azuma, Yuji Ishikawa, Shigeto Kawai, et al.Plos One|May 14, 2013
Engineered monoclonal antibody with novel antigen-sweeping activity in vivoTomoyuki Igawa, Atsuhiko Maeda, Kenta Haraya, et al.Anti-Cancer Drugs|September 18, 2010
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimizationKiyotaka Nakano, Takahiro Ishiguro, Hiroko Konishi, et al.Scientific Reports|January 3, 2024
Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancerKana Ohashi, Yukari Nishito, Hironori Fukuda, et al.Pageof 4